In patients with mild, upper respiratory tract COVID-19 without pneumonia, the levels of type I and type III (I/III) IFN-dependent interferon-stimulated gene (ISG) induction in this mucosa are correlated with serum IFN-α2 concentration and nasal SARS-CoV-2 load [42]. This evidence concerns the gene IFNA2 and pneumonia.